Soraprazan

N/A

Report date: 2025/08/22 09:58:35
NME

Base Information

Drug NameSoraprazan
Drug Alias NameRemofuscinBY-359BYK-61359
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium-transporting ATPase inhibitors
TargetsPotassium-transporting ATPase
Therapy Area/IndicationsMacular DegenerationStargardt DiseaseGastroesophageal Reflux
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMacular DegenerationStargardt Disease
Inactive IndicationsGastroesophageal Reflux

Other Information

ATC CodeN/A
Related LinksN/A